Roy Amariglio
Principal·OrbiMed
Roy Amariglio joined OrbiMed in 2016 and is a Principal on the Private Equity team. Before OrbiMed, he was Director of Mergers, Acquisitions and Licensing at Bayer Health Care and previously a Summer Associate in Life Technologies' M&A group. He is listed as a GentiBio board observer and an Averna Therapeutics board member.
See the rest of Roy Amariglio's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.